Show simple item record

dc.contributor.authorGarcía Alix, A.
dc.contributor.authorArnaez, J.
dc.contributor.authorHerranz Rubia, N.
dc.contributor.authorAlarcón, A.
dc.contributor.authorArca, G.
dc.contributor.authorValverde, E.
dc.contributor.authorBlanco, D.
dc.contributor.authorLubián López, Simón Pedro 
dc.contributor.otherMaterno-Infantil y Radiologíaes_ES
dc.date.accessioned2024-05-09T10:10:51Z
dc.date.available2024-05-09T10:10:51Z
dc.date.issued2020-09-26
dc.identifier.issn1578-1968
dc.identifier.issn0213-4853
dc.identifier.urihttp://hdl.handle.net/10498/32160
dc.description.abstractIntroduction: More than a decade has passed since therapeutic hypothermia (TH) was introduced in Spain; this is the only neuroprotective intervention that has become standard practice in the treatment of perinatal hypoxic-ischaemic encephalopathy (HIE). This article aims to provide a current picture of the technique and to address the controversies surrounding its use. Development: In the last 10 years, TH has been successfully implemented in the vast majority of tertiary hospitals in Spain, and more than 85% of newborns with moderate or severe HIE currently receive the treatment. The factors that can improve the efficacy of TH include early treatment onset (first 6 hours of life) and the control of comorbid factors associated with perinatal asphyxia. In patients with moderate HIE, treatment onset after 6 hours seems to have some neuroprotective efficacy. TH duration longer than 72 hours or deeper hypothermia do not offer greater neuroprotective efficacy, but instead increase the risk of adverse effects. Unclarified aspects are the sedation of patients during TH, the application of the treatment in infants with mild HIE, and its application in other scenarios. Prognostic information and time frame are one of the most challenging aspects.es_ES
dc.formatapplication/pdfes_ES
dc.language.isospaes_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceNeurologia, Vol. 38, Núm. 5, 2023, pp. 364-371es_ES
dc.subjectPerinatal asphyxiaes_ES
dc.subjectHypoxic-ischaemic encephalopathyes_ES
dc.subjectNeonatal encephalopathyes_ES
dc.subjectTherapeutic hypothermiaes_ES
dc.subjectNeuroprotectiones_ES
dc.subjectNeonatees_ES
dc.subjectNeurocritical carees_ES
dc.titleTen years since the introduction of therapeutic hypothermia in neonates with perinatal hypoxic-ischaemic encephalopathy in Spaines_ES
dc.title.alternativeUna década después de la implantación en España de la hipotermia terapéutica en el recién nacido con encefalopatía hipóxico-isquémica perinatales_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.nrl.2020.05.017
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional